Epimedin C Alleviates Glucocorticoid-Induced Suppression of Osteogenic Differentiation by Modulating PI3K/AKT/RUNX2 Signaling Pathway.

Xu, Yongxiang; Chen, Shichun; Huang, Linxuan; Han, Weichao; Shao, Yingying; Chen, Minyi; Zhang, Yusheng; He, Ruirong; Xie, Baocheng

Xu, Yongxiang; Chen, Shichun; Huang, Linxuan; Han, Weichao; Shao, Yingying; Chen, Minyi; Zhang, Yusheng; He, Ruirong; Xie, Baocheng.

Afiliación

Xu Y; Department of Pharmacy, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
Chen S; Department of Pharmacy, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
Huang L; Dongguan Institute of Clinical Cancer Research, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
Han W; Department of Pharmacy, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
Shao Y; Department of Pharmacy, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
Chen M; Department of Pharmacy, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
Zhang Y; Department of Pharmacy, The First People's Hospital of Foshan (The Affiliated Foshan Hospital of Sun Yat-Sen University), Foshan, China.
He R; Department of Pharmacy, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
Xie B; Department of Pharmacy, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.

Front Pharmacol ; 13: 894832, 2022.

Article en En | MEDLINE | ID: mdl-35860032

Palabras clave

PI3K; and AKT signaling pathways; dexamethasone; epimedin C; osteogenic differentiation; osteoporosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google